Commercial Solutions

Field Sales Solutions

Amplity Health Commercial Solutions designs and implements tailored, effective customer engagement field teams

Our field sales solutions engage healthcare professionals on behalf of our clients. By establishing trusted partnerships, we bring value through meaningful and continuing dialogue.

How field sales solutions can help

Depending on the specific brand objectives, Amplity Field Solutions teams can be deployed in an accountable stand-alone model or in conjunction with a traditional sales team to supplement customer engagement.

Access to experienced, skilled, and accountable pharmaceutical sales talent for product launches, growth products, and mature brand promotion

Synergistic adjunct to sales coverage for traditional sales teams

Optimal engagement at every commercial stage in the life cycle of therapeutic products

Quality customer engagements in stand-alone teams with opportunity to expand reach and/or frequency with embedded teams

Proven success

A previous Amplity Health field team implementation demonstrated the value of our tailored Amplity approach. In a blended team model (field and inside sales), this solution delivered meaningful and measurable results.

Significant market share gains

Valuable field insights and analysis

Increased access to product targets

Exceeded delivery of key performance indicators outlined by client partner

Hybrid Sales Solutions

For additional flexibility, hybrid sales representatives combine the benefits of field representatives and inside sales representatives

The hybrid sales representative can reach more HCPs and accounts with larger geographies as well as engage our client’s customers per their preference in communication: in person, remote, or digitally.

How hybrid teams can help

Hybrid representatives are equally qualified and impactful at delivering product messaging through live online meetings, web-enabled communications in-person, or by phone. All communications are also augmented with time spent in the field meeting with HCPs in person, to best address preferences for the way information is consumed.

With a deep understanding of the channel and data, we’ll partner with you to formulate the appropriate amount and type of engagement to meet the goals of your brand’s strategy.

Market Access

Committed to ensuring patients have access to the therapies they need

Market entry and growth strategies that achieve a balance between patient access and business feasibility

Amplity Market Access uses quality data and market intelligence to develop strategies that push boundaries in order to put patients first. With broad and deep knowledge of the access landscape, our talented specialists support every aspect of market access excellence. Regardless of service offering, our overarching blueprint is the same – an approach supported by data and measurable results.

Why Amplity?

Amplity has extensive experience across delivery channels (commercial, IDN, government) in a wide range of therapeutic areas. This enables us to partner with clients to ensure patients gain access to the right medicines for the right reasons. Our practice offers a rich pool of payer Key Opinion Leaders (KOLs) and many of our consultants held roles as pharmacy- and medical-benefit decision makers that drive and control the market. Our access to these unique resources, combined with our ability to leverage our medical and data assets, supports powerful market positioning for our clients.

Access trends we are helping clients navigate today

Amplity is leading the way by keeping a steady eye on current market changes and helping clients effectively manage them. The work we are doing today involves innovative tactical approaches to a wide range of market access challenges and opportunities:

Omnichannel marketing and the impact of increased virtual engagements on access
Companion diagnostics to locate patients with rare/ultra-rare diseases
Gene-therapy cost versus expense and how payers control these costs (innovative contracting toward outcomes and payment plans)
Institutional setting: Tightening of budgets with the slowing of elective procedures and reduction of staff (COVID, immunization status, etc.)
Rx access: CVS downsizing by 900 stores (announced November 21, 2021).
How will this impact patients? Mail order increase?
Impact of third parties disrupting the distribution space (e.g., Amazon and Mark Cuban launching their own pharmacies)
Generic company competition (e.g., CVS created “Red Oak” manufacturing and is distributing generics with Cardinal Health)
President Biden’s plans to address high drug prices – impact analysis and what it means for consumers
Ecosystem model impact of go-to-market implementation for many clients
Long-term care patients shifting to home health

Did you know?

Market Access Dynamics – by the numbers

Interated Delivery Networks (IDNs) own more than half of all oncology practices and administer more than half of the “buy and bill” brands
More than two-thirds of all pharamceutical claims flow through 3 PBMs: Caremark, Express Scripts, and OptumRx
Pharma companies paid $187 billion in rebates in 2020
The top 5 commercial payers own more than 50% of covered lives: OptumRx, 15%; Anthem, 13%; Aetna, 11%; Cigna, 10%; and Kaiser, 7%
Federal agencies account for 6% of covered lives, with VA/DoD accounting for more than 18.5 million beneficiaries

New Product Strategy

Amplity designs go-to-market access strategies that minimize physician hassles and patient cost-sharing barriers to support smooth market entry and adoption:

Market landscape assessments
Launch roadmaps
Strategic and tactical brand plans
Patient journey mapping
Market research
Advisory boards
Forecasting and modeling
Product positioning and competitive strategy
Surrogate account management teams

Established Product Strategy

We constantly examine the market dynamics that impact our clients’ competitive landscapes to provide targeted tactical adjustments that drive sales:

Brand diagnostics
Growth strategies
Modeling and forecasting
Market opportunity assessments
Whiteboard exploratory sessions
Companion diagnostic strategies

Pricing and Reimbursement

Leveraging our expertise and established relationships, our team facilitates the negotiation of WAC and net price combinations that exceed industry norms:

Value stories and messaging development
Payer contracting
Launch pricing
Reimbursement strategies
Competitive pricing and contracting strategies
Loss-of-exclusivity strategies

Federal Government

Amplity leverages established relationships to ensure our clients and federal decision makers are making informed choices that optimize patient access to the therapies they need.

Centers of Excellence partnerships
Freedom of Information Act data
Veterans Affairs, Department of Defense / TRICARE, and Indian Health Service optimization
Federal-agency-specific strategies and modeling
Contract modeling w/statutory pricing considerations
Federal Supply Schedule contracting
Joint National Contract optimization
Corporate exigency and stockpiling contracting
BARDA, DARPA, and NIH RFP support, account management, and collaboration design

"I learn something from you every time I am on a call with you."
- Sr. Director of Specialty Sales at mid-sized Specialty Pharma company

Are you looking for top industry talent?

Amplity Health offers best-in-class recruiting based on decades of experience and connections within the pharmaceutical and healthcare industry.

Learn About Talent Acquisition

Ready to discuss how we can partner to create better healthcare solutions?